Publications by authors named "Matthias Ruebner"

Claim this Profile
I
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Milena Beierlein, Lothar Häberle, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Matthias Ruebner

Int J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large B-cell lymphoma imprints a dysfunctional immune phenotype that persists years after treatment.
Richard J Pelzl, Giulia Benintende, Franziska Gsottberger, Julia K Scholz, Matthias Ruebner

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond deficiency: Clinical and molecular predictors of survival in patients with -deficient tubo-ovarian high-grade serous carcinoma.
Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa W Jayawardana, Matthias Ruebner

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer.
Dhanya Ramachandran, Xuemin Wang, Triin Laisk, Ying Zheng, Nathan Ingold, Matthias Ruebner

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study.
Andreas Schneeweiss, Peter A Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Matthias Ruebner

J Cancer Res Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Digital Home-Based Health Care Center for Remote Monitoring of Side Effects During Breast Cancer Therapy: Prospective, Single-Arm, Monocentric Feasibility Study.
Hanna Huebner, Lena A Wurmthaler, Chloë Goossens, Mathias Ernst, Alexander Mocker, Matthias Ruebner

JMIR Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.
Hanna Huebner, Pauline Wimberger, Elena Laakmann, Eugen Ruckhäberle, Matthias Ruebner

Precis Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of delayed isolation of peripheral blood mononuclear cells on cell viability and functionality.
Sarah Lehle, Simon Völkl, Katharina Seitz, Chloë Goossens, Julius Emons, Matthias Ruebner

BMC Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.
Reiner Hoppe, Stefan Winter, Wing-Yee Lo, Kyriaki Michailidou, Manjeet K Bolla, Matthias Ruebner

NPJ Breast Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Peter A Fasching, Carolin C Hack, Naiba Nabieva, Nicolai Maass, Bahriye Aktas, Matthias Ruebner

Eur J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients.
Marius Wunderle, Felix Heindl, Annika S Behrens, Lothar Häberle, Carolin C Hack, Matthias Ruebner

Arch Gynecol Obstet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Matthias Ruebner

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and functional follow-up of cervical cancer risk variants at the HLA locus.
Rieke Eisenblätter, Finja Seifert, Peter Schürmann, Theresa Beckhaus, Patricia Hanel, Matthias Ruebner

HLA· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial expression of claudin 18.2 in matched primaries and metastases of tubo-ovarian carcinoma of all subtypes.
Paul Wagner, Paul Gass, Patrik Pöschke, Markus Eckstein, Laura Gloßner, Matthias Ruebner

Virchows Arch· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer.
Peter A Fasching, Chunling Hu, Steven N Hart, Matthias Ruebner, Eric C Polley

NPJ Breast Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs.
Andreas Schneeweiss, Sara Y Brucker, Hanna Huebner, Lea L Volmer, Carolin C Hack, Matthias Ruebner

Geburtshilfe Frauenheilkd· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Carolin C Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Matthias Ruebner

Geburtshilfe Frauenheilkd· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Carolin C Hack, Nicolai Maass, Bahriye Aktas, Sherko Kümmel, Christoph Thomssen, Matthias Ruebner

Geburtshilfe Frauenheilkd· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer.
Lukas Heger, Gordon F Heidkamp, Lukas Amon, Falk Nimmerjahn, Tobias Bäuerle, Matthias Ruebner

Oncoimmunology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
Annika Behrens, Lena Wurmthaler, Felix Heindl, Paul Gass, Lothar Häberle, Matthias Ruebner

Geburtshilfe Frauenheilkd· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent RB1 loss and -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Matthias Ruebner

medRxiv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes and .
Tara Zuhair Kassem, Marius Wunderle, Lukas Kuhlmann, Matthias Ruebner, Hanna Huebner

Curr Issues Mol Biol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and Frequency of Germline Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.
Gisella Figlioli, Amandine Billaud, Qin Wang, Manjeet K Bolla, Joe Dennis, Matthias Ruebner

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and Acceptance of Self-Guided Mobile Ultrasound among Pregnant Women in Routine Prenatal Care.
Constanza A Pontones, Adriana Titzmann, Hanna Huebner, Nina Danzberger, Matthias Ruebner

J Clin Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer.
Raphela A Ranjan, Julienne K Muenzner, Philipp Kunze, Carol I Geppert, Matthias Ruebner

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis